Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare PBMs Could Offer "Loose" And "Tight" Rx Options - Rep. Johnson

Executive Summary

The number of prescription plan choices under Medicare could be doubled by requiring competing pharmacy benefit managers to offer both high- and low-premium drug benefits, House Ways & Means/Health Subcommittee Chairwoman Johnson (R-Conn.) suggested during a March 27 hearing.
Advertisement

Related Content

Medicare Rx: Rep. Johnson To Introduce Drug/Reform Bill In 2002
Medicare Rx: Rep. Johnson To Introduce Drug/Reform Bill In 2002
Medicare Disease Management Could End Need For Rx Benefit-CBO's Crippen
Medicare Disease Management Could End Need For Rx Benefit-CBO's Crippen
NPC Study Says New Drugs Offset Nondrug Spending: Will CBO Agree?
CBO Revised Medicare Rx Estimates Reduce Savings From PBM Techniques
CBO Remains Skeptical Of Rx Cost Savings In Medicare Estimates
PCMA Prepares For Medicare Debate: Former HHS Analyst Burton Is President
Medicare Rx Premiums Should Be Based On Ability To Pay, Sen. Grassley Says
Medicare Rx Baseline Cost Would Be $728 Bil. Over 10 Years For 50% Subsidy
Advertisement
UsernamePublicRestriction

Register

PS037594

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel